The Effect of Ascorbic Acid Deficiency on Desferrioxamine‐Induced Urinary Iron Excretion

No abstract is available for this paper.

• Publication year

  1969

• Venue

  British Journal of Haematology

• Publication date

  1969-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.1969.tb01407.xPMID 5357744
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of storage iron by chelates.

  1968cited by this paper
• Measurement of iron stores using deferoxamine.

  1968cited by this paper
• Effects of Iron Overload on Ascorbic Acid Metabolism*

  1968cited by this paper
• Determination of iron in urine with special reference to the desferrioxamine test

  1967cited by this paper
• Accelerated oxidative catabolism of ascorbic acid in siderotic Bantu.

  1967cited by this paper
• Differential ferrioxamine test in idiopathic haemochromatosis and transfusional haemosiderosis

  1966cited by this paper
• Sideruria following a Single Dose of Desferrioxamine‐B as a Diagnostic Test in Iron Overload

  1966cited by this paper
• DESFERRIOXAMINE EFFECT ON IRON EXCRETION IN HEMOCHROMATOSIS.

  1964cited by this paper
• The quantitative estimation of total iron stores in human bone marrow.

  1963cited by this paper
• Synthetic chelating agents in iron metabolism.

  1963cited by this paper
• Effect of Desferrioxamine and D.T.P.A. in Iron Overload

  1962influential reference
• The determination of ascorbic acid in white blood cells. A comparison of W.B.C. ascorbic acid and phenolic acid excretion in elderly patients.

  1961cited by this paper
• The determination of ascorbic acid in white blood cells. A comparison of W.B.C. ascorbic acid and phenolic acid excretion in elderly patients.

  1961cited by this paper
• Siderosis in the Bantu. A combined histopathological and chemical study.

  1960cited by this paper
• The mechanism of iron release from ferritin as related to its biological properties.

  1955cited by this paper

• Unusual Micronutrient Deficiencies as Causes of Anemia.

  2026cites this paper
• 19. Nutrition for patients with thalassemia

  2016cites this paper
• THERAPEUTIC ADVANCEMENTS IN MANAGEMENT OF IRON OVERLOAD-A REVIEW Review Article

  2015cites this paper
• Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.

  2013cites this paper
• A mechanistic study of ferrioxamine B reduction by the biological reducing agent ascorbate in the presence of an iron(II) chelator

  2009cites this paper
• Disorders of Hemoglobin: THE β THALASSEMIAS

  2009cites this paper
• Iron chelation using subcutaneous infusions of diethylene triamine penta-acetic acid (DTPA).

  2009cites this paper
• Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.

  2005cites this paper
• Desferrioxamine mesylate for managing transfusional iron overload in people with thalassaemia

  2003cites this paper
• Results of long term iron chelation treatment with deferoxamine.

  2002cites this paper
• Cardiac function during iron chelation therapy in adult non‐thalassaemic patients with transfusional iron overload

  1997cites this paper
• Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy.

  1996cites this paper
• CRITICAL REVIEW OF STANDARD AND NEW METHODS OF ASSESSING COMPLIANCE WITH CHELATION THERAPY IN THALASSEMIC PATIENTS

  1995cites this paper
• Etiologies, consequences, and treatment of iron overload.

  1994cites this paper
• Treatment of iron-deficiency anemia complicated by scurvy and folic acid deficiency.

  1992cites this paper
• Iron chelation.

  1990cites this paper
• Mechanism of iron toxicity and its possible role in red cell membrane damage.

  1989cites this paper
• 4 Desferrioxamine-induced iron excretion in humans

  1989cites this paper
• Desferrioxamine-induced iron excretion in humans.

  1989cites this paper
• Iron-chelating therapy.

  1988cites this paper
• Management of beta-thalassemia major using transfusions and iron chelation with deferoxamine.

  1988cites this paper
• Iron overload and iron chelation therapy in thalassaemia and sickle cell haemoglobinopathies.

  1987cites this paper
• Current concepts in the management of thalassemia

  1987cites this paper
• Modification of iron uptake and lipid peroxidation by hypoxia, ascorbic acid, and alpha-tocopherol in iron-loaded rat myocardial cell cultures.

  1987cites this paper
• High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis

  1986influential citation
• Iron mobilization from isolated hepatocytes.

  1986cites this paper
• Transfusional iron overload.

  1985cites this paper
• Thalassemia.

  1984cites this paper
• Effect of ascorbic acid on desferrioxamine-induced urinary iron excretion in idiopathic hemochromatosis.

  1984cites this paper
• The role of ascorbic acid in the turnover of storage iron.

  1983cites this paper
• The present status of chelating agents in medicine.

  1983cites this paper
• Early iron chelation therapy in thalassemia major.

  1983cites this paper
• Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.

  1983cites this paper
• Clinical removal of iron.

  1982cites this paper
• Ferrioxamine excretion in iron-loaded man.

  1982cites this paper
• A mathematical model of iron chelation with desferrioxamine

  1982cites this paper
• Chelation therapy in iron poisoning.

  1982cites this paper
• Assessment of bone marrow and body iron stores: old techniques and new technologies.

  1981cites this paper
• [Treatment and prevention of chronic iron overload (author's transl)].

  1981cites this paper
• Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods.

  1981cites this paper
• [Hemochromatosis].

  1981cites this paper
• Intravenous and subcutaneous desferrioxamine therapy in children with severe iron overload

  1981cites this paper
• Assessment of liver iron content in 271 patients: A reevaluation of direct and indirect methods

  1981cites this paper
• Response to long-term deferoxamine therapy in thalassemia.

  1981cites this paper
• Iron absorption and iron overload.

  1981cites this paper
• Scurvy and altered iron stores in thalassemia major.

  1981cites this paper
• Idiopathic hemochromatosis, an interim report.

  1980cites this paper
• Serum Ferritin in Ascorbic Acid Deficiency

  1980cites this paper
• Clinical management of beta-thalassemia.

  1980cites this paper
• [Idiopathic haemochromatosis. Pathogenic and genetic aspects. Detection and prevention (author's transl)].

  1979cites this paper
• Hemochromatosis caused by excessive vitamin iron intake.

  1979cites this paper
• Iron chelation therapy in sickle cell anemia

  1979cites this paper
• Annotation IRON CHELATION THERAPY FOR IRON LOADED PATIENTS

  1979cites this paper
• Iron chelation therapy for iron loaded patients.

  1979cites this paper
• Detection of early cardiac dysfunction in patients with severe beta-thalassemia and chronic iron overload.

  1979cites this paper
• The antioxidant vitamins.

  1979cites this paper
• Intensive iron-chelation therapy with desferrioxamine in iron-loading anaemias.

  1978cites this paper
• Kontrollierte Desferrioxamin-Therapie bei kongenitaler Anämie und Transfusionssiderose

  1978cites this paper
• Prevention of iron loading in transfusion-dependent thalassaemia.

  1978cites this paper
• Iron chelation therapy with deferoxamine in Cooley anemia.

  1978cites this paper
• Ascorbic acid status in idiopathic hemochromatosis.

  1978cites this paper
• Iron metabolism: clinical chronobiological aspects.

  1978cites this paper
• Excretion of iron in response to deferoxamine in sickle cell anemia.

  1978cites this paper
• Desferrioxamine and transfusional iron overload.

  1978cites this paper
• [Controlled desferrioxamine treatment of congenital anaemia and transfusion siderosis (author's transl)].

  1978cites this paper
• Krankheiten des Hämoglobinstoffwechsels

  1977cites this paper
• Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine.

  1977cites this paper
• Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron Overload

  1977cites this paper
• Total management of thalassaemia major.

  1977cites this paper
• Iron overload--clinical and pathologic aspects.

  1977cites this paper
• Iron overload: clinical and pathologic aspects in pediatrics.

  1977cites this paper
• Iron absorption in iron-loading anaemias: Effect of subcutaneous desferrioxamine infusions.

  1977cites this paper
• Reassessment of the use of desferrioxamine B in iron overload.

  1976cites this paper
• The Inhibitory Effect of Vitamin E on Desferrioxamine-Induced Iron Excretion in Rats 1

  1976cites this paper
• The effect of chelating agents on cellular iron metabolism.

  1976cites this paper
• Influence of iron and ascorbic acid on tryptophan metabolism in man.

  1975cites this paper
• Thalassemia Major: A Problem of Iron Overload

  1974cites this paper
• ASCORBIC ACID ENHANCEMENT OF DESFERRIOXAMINE‐INDUCED URINARY IRON EXCRETION IN THALASSEMIA MAJOR *

  1974cites this paper
• Editorial: Thalassemia major: a problem of iron overload.

  1974cites this paper
• The identification of 2, 3-dihydroxybenzoic acid as a potentially useful iron-chelating drug.

  1974cites this paper
• LONG‐TERM DESFERRIOXAMINE THERAPY IN THALASSEMIA

  1974cites this paper
• Iron storage disorders of the liver.

  1974cites this paper
• Iron and the liver.

  1974cites this paper
• Storage iron kinetics. 3. Study of desferrioxamine action by selective radioiron labels of RE and parenchymal cells.

  1973cites this paper
• Hemoglobinopathies of clinical importance.

  1972cites this paper
• Effects of iron overload on lipid peroxide formation and oxidative demethylation by the liver endoplasmic reticulum.

  1972cites this paper
• Iron absorption and distribution in normal and scorbutic guinea pigs.

  1972cites this paper
• Ascorbic acid status in iron-deficiency anaemia

  1971cites this paper
• The Site of Action of Desferrioxamine

  1971cites this paper
• Management of thalassaemia major.

  1971cites this paper
• The effect of supplementary vitamin C on haemopoiesis during adolescence.

  1971cites this paper
• The Relationship between Serum Iron Levels and Ascorbic Acid Stores in Siderotic Bantu

  1970cites this paper
• Effect of ascorbic acid on desferrioxamine therapy.

  1970cites this paper
• [Erythroblastic aplasia in an adolescent].

  1970cites this paper
• Storage iron and desferrioxamine.

  1970cites this paper
• Iron Balance and its Disorders

  1970cites this paper
• Progress report Iron and the liver

  year unknowncites this paper